Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 1, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Pacira Biosciences, Inc.
| -119.32K |
$30.64 | -$3,656,226.39 | -84.36% | 22.13K |
Mar 6 - Mar 8
| |||||||
Cardiff Oncology, Inc.
| 30K |
$1.37 | $41,100.00 | +4.49% | 697.76K |
Dec 19
| |||||||
Cardiff Oncology, Inc.
| 22.95K |
$0.98 | $22,491.00 | +3.56% | 667.76K |
Nov 10
| |||||||
Cardiff Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Pacira Biosciences, Inc.
| 1.77K |
—
|
—
| +1.27% | 141.45K |
Jun 14
| |||||||
Pacira Biosciences, Inc.
| 1.99K |
$35.84 | -$226.70 | +1.44% | 139.68K |
May 11
| |||||||
Cardiff Oncology, Inc.
| 150K |
$1.71 | $256,500.00 | +30.31% | 644.81K |
Sep 15
| |||||||
Pacira Biosciences, Inc.
| 1.16K |
—
|
—
| +0.85% | 137.69K |
Jun 8
| |||||||
Cardiff Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 9
| |||||||
Pacira Biosciences, Inc.
| 7K |
$10.81 | $75,670.00 | +5.40% | 136.53K |
Mar 3
| |||||||
Pacira Biosciences, Inc.
|
0
|
$38.95 | -$1,675,550.28 |
—
| 129.53K |
Feb 28 - Mar 1
| |||||||
Cardiff Oncology, Inc.
| 30K |
$6.75 | $202,500.00 | +6.45% | 494.81K |
Sep 21
| |||||||
Cardiff Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Pacira Biosciences, Inc.
| -419.00 |
—
|
—
| -0.32% | 129.53K |
May 13 - Jun 9
| |||||||
Cardiff Oncology, Inc.
| 10K |
$10.23 | $102,300.00 | +2.20% | 464.81K |
Mar 23
| |||||||
Cardiff Oncology, Inc.
| 3K |
$10.55 | $31,660.00 | +0.66% | 454.81K |
Mar 18
| |||||||
Cardiff Oncology, Inc.
| 1.5K |
$9.27 | $13,897.50 | +0.33% | 451.81K |
Mar 4
| |||||||
Pacira Biosciences, Inc.
| 70K |
$16.67 | $1,166,900.00 | +116.77% | 129.95K |
Sep 25
| |||||||
Cardiff Oncology, Inc.
| 2.55K |
$5.70 | $14,526.50 | +0.57% | 450.31K |
Sep 16
| |||||||
Cardiff Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Pacira Biosciences, Inc.
| 1.26K |
—
|
—
| +2.15% | 59.95K |
Jun 9
| |||||||
Cardiff Oncology, Inc.
| 447.76K |
$1.34 | $599,999.74 |
∞
| 447.76K |
May 11
| |||||||
Trovagene, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 16
| |||||||
Trovagene, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Pacira Biosciences, Inc.
| 21.74K |
$4.46 | $96,844.96 | +58.82% | 58.69K |
Mar 12
| |||||||
Pacira Biosciences, Inc.
| 4.13K |
—
|
—
| +12.60% | 36.95K |
Jun 5
| |||||||
Pacira Pharmaceuticals, Inc.
| 4.5K |
$46.18 | $207,810.00 | +15.89% | 32.82K |
Nov 19
| |||||||
Pacira Pharmaceuticals, Inc.
| 4K |
$51.29 | $205,160.00 | +16.45% | 28.32K |
Nov 7
| |||||||
Pacira Pharmaceuticals, Inc.
| 782 |
—
|
—
| +3.32% | 24.32K |
Jun 13
| |||||||
Resmed Inc
|
0
|
$62.48 | -$1,982,245.37 |
—
| 100.58K |
May 8
| |||||||
Resmed Inc
| 2.99K |
—
|
—
| +3.06% | 100.58K |
Nov 16
| |||||||
Pacira Pharmaceuticals, Inc.
| 1.36K |
—
|
—
| +6.12% | 23.54K |
Jun 14
| |||||||
Resmed Inc
|
0
|
$54.85 | -$1,031,697.00 |
—
| 97.59K |
Jun 14 - Jun 15
|
Scheduled
| ||||||
Resmed Inc
| 4.43K |
—
|
—
| +4.75% | 97.59K |
Nov 16
| |||||||
Resmed Inc
|
0
|
$47.74 | -$1,597,896.00 |
—
| 93.16K |
Aug 19
| |||||||
Pacira Pharmaceuticals, Inc.
| 1.49K |
—
|
—
| +7.19% | 22.18K |
Jun 15
| |||||||
Resmed Inc
|
0
|
$41.94 | -$1,300,500.00 |
—
| 93.16K |
Mar 11
|
Scheduled
| ||||||
Resmed Inc
|
0
|
—
|
—
|
—
|
0
|
Nov 19
| |||||||
Pacira Pharmaceuticals, Inc.
| 2K |
—
|
—
| +10.70% | 20.69K |
Jun 3
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.